Comparing Strata Skin Sciences (NASDAQ:SSKN) and Patient Portal Technologies (OTCMKTS:PPRG)

Patient Portal Technologies (OTCMKTS:PPRGGet Free Report) and Strata Skin Sciences (NASDAQ:SSKNGet Free Report) are both medical companies, but which is the better business? We will contrast the two companies based on the strength of their dividends, valuation, institutional ownership, earnings, profitability, risk and analyst recommendations.

Analyst Ratings

This is a breakdown of current ratings for Patient Portal Technologies and Strata Skin Sciences, as reported by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Patient Portal Technologies 0 0 0 0 0.00
Strata Skin Sciences 1 0 0 0 1.00

Given Patient Portal Technologies’ higher possible upside, equities research analysts clearly believe Patient Portal Technologies is more favorable than Strata Skin Sciences.

Institutional and Insider Ownership

32.4% of Strata Skin Sciences shares are held by institutional investors. 40.9% of Strata Skin Sciences shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Profitability

This table compares Patient Portal Technologies and Strata Skin Sciences’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Patient Portal Technologies N/A N/A N/A
Strata Skin Sciences -35.64% -476.73% -33.49%

Earnings & Valuation

This table compares Patient Portal Technologies and Strata Skin Sciences”s revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Patient Portal Technologies N/A N/A N/A N/A N/A
Strata Skin Sciences $30.98 million 0.03 -$10.09 million ($1.41) -0.12

Patient Portal Technologies has higher earnings, but lower revenue than Strata Skin Sciences.

About Patient Portal Technologies

(Get Free Report)

Patient Portal Technologies, Inc. provides patient relationship management solutions for healthcare facilities, patients and families, and medical personnel. It offers HEALTHCAST, a multi-channel, television network for the delivery of customized information and education to patients, visitors, and staff; MEDEX PRESCRIPTION DELIVERY, a free prescription medication delivery solution; and PHONE & TV RENTAL, an interactive communication center, and billing and collection platform. The company also provides TELCIERGE INSTANT RESPONSE that puts patients in control of non-medical needs through a single phone call; QUICK PULSE SURVEYS that provide feedback for improved operations; and MEDCLIPS, which provide condition specific video clips for internal or remote viewing before or after hospital stay. Patient Portal Technologies, Inc. is based in Baldwinsville, New York.

About Strata Skin Sciences

(Get Free Report)

STRATA Skin Sciences, Inc., a medical technology company, develops, commercializes, and markets products for the treatment of dermatologic conditions in the United States, Europe, the Middle East, Asia, Australia, South Africa, and Central and South America. The company operates in two segments, Dermatology Recurring Procedures and Dermatology Procedures Equipment. The company products include XTRAC and Pharos excimer lasers, and VTRAC lamp systems for the treatment systems that are used for the treatment of psoriasis, vitiligo, and other skin conditions. It also offers TheraClear Acne Therapy System for the treatment of mild to moderate inflammatory, comedonal, and pustular acne. The company was formerly known as MELA Sciences, Inc and changed its name to STRATA Skin Sciences, Inc. in January 2016. STRATA Skin Sciences, Inc. was incorporated in 1989 and is based in Horsham, Pennsylvania.

Receive News & Ratings for Patient Portal Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Patient Portal Technologies and related companies with MarketBeat.com's FREE daily email newsletter.